Efficacy and Safety of Oral Liposomal Versus Conventional Iron in Anemic Children With CKD Stages 3-5, not Treated With Hemodialysis: A Randomized Controlled Trial
Efficacy and Safety of Oral Liposomal Versus Conventional Iron in Anemic Children With CKD Stages 3-5, not Treated With Hemodialysis: A Randomized Controlled Trial. // Kidney Medicine. – URL: https://www.sciencedirect.com/science/article/pii/S2590059526002505?dgcid=rss_sd_all
Efficacy and Safety of Oral Liposomal Versus Conventional Iron in Anemic Children With CKD Stages 3-5, not Treated With Hemodialysis: A Randomized Controlled Trial. Kidney Medicine. https://www.sciencedirect.com/science/article/pii/S2590059526002505?dgcid=rss_sd_all
“Efficacy and Safety of Oral Liposomal Versus Conventional Iron in Anemic Children With CKD Stages 3-5, not Treated With Hemodialysis: A Randomized Controlled Trial.” Kidney Medicine.
@article{article117316,
title = {Efficacy and Safety of Oral Liposomal Versus Conventional Iron in Anemic Children With CKD Stages 3-5, not Treated With Hemodialysis: A Randomized Controlled Trial},
journal = {Kidney Medicine},
url = {https://www.sciencedirect.com/science/article/pii/S2590059526002505?dgcid=rss_sd_all}
}
Abstract Background Macrophage polarisation plays a crucial role in sepsis‐associated inflammatory responses; however, the underlying molecular regulatory mechanisms remain to be further explored. Aim This study aimed to explore the...